This article was published on CannabisFN
Pazoo Inc. , a provider of best-in-class laboratory testing of cannabis and cannabinoids, recently announced that its Colorado licensee, Harris Lee, has already started to receive payments on invoiced billed less than two weeks ago. CEO David Cunic noted that the team was encouraged by the volume of the samples that the licensee has been processing since taking over management of the lab following regulatory approvals.
The company’s sales and marketing campaigns are underway and generating new customer sales appointments every business day. These efforts will be supported with a business-to-business marketing campaign to further increase the Steep Hill Colorado brand name.
Read the entire press release here:
Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to announce that its Colorado licensee, Harris Lee Colorado, LLC, the management company of Steep Hill Colorado, has already started to receive payments on its invoices which were billed less than 2 weeks ago.
The quick payment of these invoices indicates the quality and commitment of the Harris Lee Colorado customers. In addition to substantial increase in sales, the sales marketing campaigns currently underway are generating new customer sales appointments every business day and Harris Lee Colorado has moved its sales strategy forward as quickly as it had planned to. The sales marketing plan will shortly be supported with a business to business marketing campaign to further increase Steep Hill Colorado brand awareness.
Pazoo, Inc., CEO David Cunic stated, “We are extremely encouraged by the volume of the samples Harris Lee Colorado has been processing since taking over management of the Colorado lab following the recent approval from the M.E.D. We expect these numbers to improve steadily as the right employees are put in place and as they continue their aggressive sales marketing efforts. Every new test represents licensing revenue for Pazoo.”
About Pazoo, Inc.:
Pazoo, Inc. is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee and MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo is licensed to test cannabis in Nevada, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its websitewww.pazoo.com, and features industry experts from both the health and wellness arena and the pet industry. Lastly, our newly formed wholly owned subsidiary CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the USA. Non-controlled hemp products are the items utilized by the industry that support grow facilities, infusion companies and dispensaries.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.